Advanced Treatment Options for Metastatic Prostate Cancer
22 hours ago · Advanced treatment depends heavily on whether the cancer still responds to hormone suppression. Metastatic hormone-sensitive prostate cancer (mHSPC): Still responds to lowering …
FDA Greenlights Niraparib/Abiraterone Acetate With Prednisone in mHSPC …
6 days ago · The FDA has approved niraparib and abiraterone acetate with prednisone for the treatment of patients with BRCA2-mutated metastatic hormone-sensitive prostate cancer.
PTEN Loss and the Future of Precision Treatment in mHSPC - Karim …
3 days ago · Phase III CAPItello-281 Trial Results for mHSPC with PTEN Loss - Karim Fizazi Analysis of the Phase III CAPItello-281 Trial: Capivasertib plus Abiraterone in PTEN-Deficient Metastatic …
U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2 ...
Metastatic castration-sensitive prostate cancer (mCSPC), also known as metastatic hormone-sensitive prostate cancer (mHSPC), refers to prostate cancer that has spread to other parts of the body but …
Treatment of Metastatic Hormone-Sensitive Prostate Cancer
Treatment of metastatic prostate cancer is generally based on whether its growth can be slowed or stopped with hormone therapy. Recall that testosterone (an androgen hormone) is the “fuel” that …
Updated treatment recommendations for prostate cancer from the …
Mar 21, 2023 · The following ESMO Clinical Practice Guideline has been recently updated with new treatment recommendations: Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, …
Combination Therapies in Locally Advanced and Metastatic Hormone ...
This narrative collaborative review summarises the data behind combination treatment approaches for locally advanced prostate cancer (LAPC) and mHSPC, and discusses on-going challenges and …
U.S. FDA approves third indication of Bayer blockbuster Nubeqa ...
Jun 3, 2025 · Nubeqa is the first and only in the U.S. and FDA-approved androgen receptor inhibitor (ARi) for the treatment of patients with hormone-sensitive prostate cancer (mHSPC), in combination …
Advances in Current Treatment Paradigms for Metastatic Hormone
Apr 8, 2025 · Given ongoing advancements in metastatic prostate cancer treatment, a deeper understanding of the epidemiology, disease progression, and therapeutic strategies for metastatic …
Truqap combination in PTEN-deficient metastatic hormone-sensitive ...
Nov 25, 2024 · Prostate cancer is the second most prevalent cancer in men and the fifth leading cause of male cancer death globally. 1 Only one third of patients with metastatic prostate cancer survive …